Profile

Savan Devani

Contact Details

Bio

Savan is the Founder and CEO at BioTrillion. Savan has spent his entire professional and academic life in life sciences, including 14 years working with hundreds of public and private corporations as a Healthcare Investment Banker at Citigroup (NYSE: C), Deutsche Bank (NYSE: DB). From Analyst through Managing Director, Savan executed 40 M&A, IPO, and financing deals, totaling over $35 billion in value, and experienced many invaluable business and scientific lessons from his work with clients across the spectrum of drug, diagnostic, and device technologies. These companies included Amgen, Anacor, Boston Scientific, Eli Lilly, Intermune, Map Pharma, Masimo, Medtronic, Omeros, Pacific Biosciences, and many others. While a Vice President at Deutsche Bank, he was selected to lead the firm's build-out of its healthcare business into Asia, leading to two of China's largest IPO's – Shanghai Pharma and Fosun Pharma. Savan began his career as a Bioengineer at Life Technologies (NYSE: TMO). Savan graduated with a M.S.E. in Bioengineering from the University of Pennsylvania and a B.S.E. in Bioengineering focused in Computer Science from the University of California at Berkeley. After many years of academic and professional experience in the healthcare field, a painful personal experience later in life gave Savan new perspective into how much healthcare needed to change – his mother was abruptly diagnosed with stage 4 cancer. This compelled Savan to ask “where were all the signs” and “isn't there a better way,” which led to him returning to his Bioengineering roots and founding BioTrillion.